Although FCSL will not be attending, we would like to highlight the following meeting: The Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting provides a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.

PANWAT 2018 Date: October 14-15 Location: Hilton Garden Inn, Bothell, WA, on Sunday (6-8pm) Seattle Genetics, Bothell, WA, on Monday (8:30am-5pm)

Flow Contract Site Laboratory (FCSL) is turning 9! Founded by Lynette Brown and Jennifer J Stewart in 2009, FCSL has spent the last 9 years striving for excellence. We boast personalized customer service, comprehensive reporting, and turn-around time that have no equal. We have experienced major growth and have relocated twice within the last couple […]

EMT6 is an epithelial tumor of the mammary glands of BALB/cCrgl Mus musculus. This tumor has produced an adherent cell that requires storage in liquid nitrogen. EMT6 has been used in mice to study the antitumor potential of Cutibacterium (Propionibacterium) acnes, the bacteria responsible for acne in humans, and melatonin.

Tumor studies performed in mice are helping the medical community learn better ways to diagnose and treat cancer in humans. One of the most virulent tumors is the 4T1 tumor, a mouse tumor of the mammary gland.

As a contract flow lab, FCSL frequently runs immunophenotyping assays for clients, though it is just one of the flow cytometry services we offer. CD Markers are commonly used in immunophenotyping to identify cells based on what molecules are present on the surface of each cell.

More women are working outside of the home than ever. While women make up 47% of all US jobs, they only make up a small percentage of the Science, Technology, Engineering, and Mathematics (STEM) jobs. However, this is not because fewer women possess a college education; a little more than half of college educated workers […]